Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Genequantum Healthcare (suzhou) Co., Ltd.

Clinical trials sponsored by Genequantum Healthcare (suzhou) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug GQ1005 takes on T-DM1 in advanced HER2-Positive breast cancer Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug GQ1005 takes on T-DM1 in advanced HER2-Positive breast cancer

Disease control Recruiting now

This phase 3 trial tests whether a new drug called GQ1005 works better than the current standard treatment T-DM1 for people with HER2-positive breast cancer that has spread or cannot be removed by surgery. Participants have already been treated with trastuzumab and a taxane. The …

Phase 3 • Sponsor: GeneQuantum Healthcare (Suzhou) Co., Ltd. • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC